These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30856117)

  • 1. Cysteamine Protects Neurons from Mutant Huntingtin Toxicity.
    Arbez N; Roby E; Akimov S; Eddings C; Ren M; Wang X; Ross CA
    J Huntingtons Dis; 2019; 8(2):129-143. PubMed ID: 30856117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor.
    Eddings CR; Arbez N; Akimov S; Geva M; Hayden MR; Ross CA
    Neurobiol Dis; 2019 Sep; 129():118-129. PubMed ID: 31108174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Effects of σ
    Jin J; Arbez N; Sahn JJ; Lu Y; Linkens KT; Hodges TR; Tang A; Wiseman R; Martin SF; Ross CA
    ACS Chem Neurosci; 2022 Oct; 13(19):2852-2862. PubMed ID: 36108101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease.
    Yin X; Manczak M; Reddy PH
    Hum Mol Genet; 2016 May; 25(9):1739-53. PubMed ID: 26908605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity.
    Arbez N; Ratovitski T; Roby E; Chighladze E; Stewart JC; Ren M; Wang X; Lavery DJ; Ross CA
    J Biol Chem; 2017 Nov; 292(47):19238-19249. PubMed ID: 28972180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice.
    Sun L; Xu S; Zhou M; Wang C; Wu Y; Chan P
    Brain Res; 2010 Jun; 1335():74-82. PubMed ID: 20380823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation.
    Vidoni C; Secomandi E; Castiglioni A; Melone MAB; Isidoro C
    Neurochem Int; 2018 Jul; 117():174-187. PubMed ID: 28532681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
    Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
    J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.
    Luis-Ravelo D; Estévez-Silva H; Barroso-Chinea P; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Acevedo-Arozena A; Marcellino D; González-Hernández T
    Exp Neurol; 2018 Jan; 299(Pt A):137-147. PubMed ID: 29056363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin Protects Cells from Mutant Huntingtin Toxicity Through Activation of AMPK and Modulation of Mitochondrial Dynamics.
    Jin J; Gu H; Anders NM; Ren T; Jiang M; Tao M; Peng Q; Rudek MA; Duan W
    Neuromolecular Med; 2016 Dec; 18(4):581-592. PubMed ID: 27225841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
    Fox JH; Barber DS; Singh B; Zucker B; Swindell MK; Norflus F; Buzescu R; Chopra R; Ferrante RJ; Kazantsev A; Hersch SM
    J Neurochem; 2004 Oct; 91(2):413-22. PubMed ID: 15447674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Fos Protects Neurons Through a Noncanonical Mechanism Involving HDAC3 Interaction: Identification of a 21-Amino Acid Fragment with Neuroprotective Activity.
    Rawat V; Goux W; Piechaczyk M; D Mello SR
    Mol Neurobiol; 2016 Mar; 53(2):1165-1180. PubMed ID: 25592718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells.
    Mao Z; Choo YS; Lesort M
    Eur J Neurosci; 2006 Apr; 23(7):1701-10. PubMed ID: 16623826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
    Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
    Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.
    Borrell-Pagès M; Canals JM; Cordelières FP; Parker JA; Pineda JR; Grange G; Bryson EA; Guillermier M; Hirsch E; Hantraye P; Cheetham ME; Néri C; Alberch J; Brouillet E; Saudou F; Humbert S
    J Clin Invest; 2006 May; 116(5):1410-24. PubMed ID: 16604191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity.
    Pan Y; Daito T; Sasaki Y; Chung YH; Xing X; Pondugula S; Swamidass SJ; Wang T; Kim AH; Yano H
    Sci Rep; 2016 Aug; 6():31022. PubMed ID: 27516062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease.
    Zeng Y; Guo W; Xu G; Wang Q; Feng L; Long S; Liang F; Huang Y; Lu X; Li S; Zhou J; Burgunder JM; Pang J; Pei Z
    Drug Des Devel Ther; 2016; 10():1443-51. PubMed ID: 27110099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLP-1 Analogue Liraglutide Attenuates Mutant Huntingtin-Induced Neurotoxicity by Restoration of Neuronal Insulin Signaling.
    Chang CC; Lin TC; Ho HL; Kuo CY; Li HH; Korolenko TA; Chen WJ; Lai TJ; Ho YJ; Lin CL
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal Huntingtin Knock-In Mice: Implications of Removing the N-terminal Region of Huntingtin for Therapy.
    Liu X; Wang CE; Hong Y; Zhao T; Wang G; Gaertig MA; Sun M; Li S; Li XJ
    PLoS Genet; 2016 May; 12(5):e1006083. PubMed ID: 27203582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.